Bacteria-Resistant Coating on Catheters Reduces Infection and Need for Antibiotics

Why It Matters

Reducing CAUTIs cuts hospital costs, shortens stays, and curtails antibiotic resistance, a critical public‑health priority. The breakthrough offers a scalable, preventive solution for a pervasive healthcare‑associated infection.

Key Takeaways

• Coated catheters cut CAUTI rates by one‑third
• Antibiotic use dropped over 50% with coated catheters
• Long‑term patients showed zero symptomatic CAUTIs versus 20% standard
• Polymer coating prevents biofilm formation without killing bacteria
• Camstent scaling production to meet global catheter demand

Pulse Analysis

Catheter‑associated urinary tract infections remain a leading cause of hospital‑acquired infections, representing roughly 75 % of all UTIs in clinical settings. Each year, millions of patients receive indwelling urinary catheters, and between 10 % and 25 % develop a CAUTI, driving longer stays and higher costs. The reliance on broad‑spectrum antibiotics to treat these infections fuels growing resistance, prompting clinicians and manufacturers to seek preventative solutions that address the source rather than the symptoms.

A collaborative effort between the University of Nottingham and medical‑device firm Camstent has produced a polymer coating that repels bacteria and blocks biofilm formation on catheter surfaces. Unlike antimicrobial agents that kill microbes, the coating creates a non‑adhesive barrier, reducing attachment of common pathogens such as E. coli and S. aureus. In a multicenter randomized trial published in Antibiotics, patients using the coated catheters experienced a 33 % reduction in CAUTI incidence and a 55 % drop in antibiotic prescriptions, with long‑term users reporting zero symptomatic infections.

The clinical success positions Camstent to accelerate commercialization across the United Kingdom and pursue broader international roll‑outs. Scaling production through automation will help meet the estimated weekly demand for millions of catheters worldwide while preserving quality. Health systems stand to save on treatment costs, reduce antibiotic consumption, and improve patient outcomes, making the technology a compelling addition to infection‑control portfolios. As antimicrobial resistance intensifies, preventive device innovations like this coating could become a new standard of care in hospitals and long‑term care facilities.